tirzepatide elevated heart rate Effects of tirzepatide, a dual GIP and GLP-1 receptor agonist, on blood pressure, cardiac function, and sympathetic nervous system in stroke-prone spontaneously hypertensive rats Should a patient with tachycardia
Description
Working with a healthcare team helps in understanding and managing the potential risks linked to tirzepatide
Nature 629 , 624629 (2024)
Average weight loss results are generally lower than tirzepatide but still significant for many users
What the data consistently shows is a pattern common to this entire class of compounds: gastrointestinal side effects are prevalent but transient, serious adverse events are rare, and the most clinically meaningful outcomes (blood sugar control, blood pressure, lipids, body weight) move substantially in the right direction
